Published in AIDS on November 01, 1991
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol (1993) 2.94
Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol (1996) 1.78
Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol (1994) 1.50
Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol (1995) 1.23
Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci U S A (1997) 1.05
Cytopathic mechanisms of HIV-1. Virol J (2007) 0.97
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
HIV-1 nef protein structures associated with brain infection and dementia pathogenesis. PLoS One (2011) 0.91
Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol (1994) 0.89
T helper cell activation and human retroviral pathogenesis. Microbiol Rev (1996) 0.88
HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol (2012) 0.86
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review. Am J Infect Dis (2009) 0.86
Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins. J Virol (1993) 0.85
HIV Associated Neurocognitive Disorders. Infect Dis Rep (2013) 0.84
Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders. J Neuroimmune Pharmacol (2008) 0.83
Alterations in intracellular potassium concentration by HIV-1 and SIV Nef. Virol J (2008) 0.78
Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels. Retrovirology (Auckl) (2008) 0.78
HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity. PLoS One (2015) 0.75
Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol (2000) 14.74
In-vivo measurement of activated microglia in dementia. Lancet (2001) 3.51
Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature (1992) 3.39
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med (2001) 3.32
Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett (1995) 3.28
Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med (2000) 3.10
Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev (1995) 2.92
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
Functional plasticity of microglia: a review. Glia (1988) 2.76
Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev (1999) 2.57
Neuronal dynamics and axonal flow. IV. Blockage of intra-axonal enzyme transport by colchicine. Proc Natl Acad Sci U S A (1969) 2.30
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Cytotoxicity of microglia. Glia (1993) 2.29
Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol (1998) 2.06
Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature (1990) 2.06
First pass annotation of promoters on human chromosome 22. Genome Res (2001) 1.99
Lectin binding by resting and reactive microglia. J Neurocytol (1987) 1.96
Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci (1998) 1.87
The anticancer drug imatinib induces cellular autophagy. Leukemia (2007) 1.84
Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS (1999) 1.84
Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J Comp Neurol (1998) 1.67
Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo. J Cell Biol (2001) 1.50
PK ('peripheral benzodiazepine')--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol (1997) 1.49
Human SSAV-related endogenous retroviral element: LTR-like sequence and chromosomal localization to 18q21. Genomics (1989) 1.49
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology (2000) 1.47
Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut (2002) 1.41
Significance of restricted HIV expression for HIV neuropathogenesis: still an unresolved issue. AIDS (1997) 1.41
Radiation therapy treatment verification imaging in Australia and New Zealand. J Med Imaging Radiat Oncol (2008) 1.38
Identity of ED2-positive perivascular cells in rat brain. J Neurosci Res (1989) 1.38
Mutagenesis and transformation of normal cells by chemical carcinogens. Nature (1976) 1.37
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol (1998) 1.36
Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol (1988) 1.36
Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology (2001) 1.36
Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res (1988) 1.36
[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology (1999) 1.36
Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett (1988) 1.35
New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury. J Neuroimmunol (1990) 1.34
Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT). Eur J Neurosci (2000) 1.30
Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J Gen Virol (1984) 1.29
Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. J Neurol Neurosurg Psychiatry (2005) 1.29
In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain (2001) 1.26
Impaired axonal regeneration in alpha7 integrin-deficient mice. J Neurosci (2000) 1.25
Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J Neurosci Res (2001) 1.24
Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol (1989) 1.24
Genomic distribution and transcription of solitary HERV-K LTRs. Genomics (1993) 1.24
Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol (1995) 1.23
Prevention of Ca(2+)-mediated action potentials in GABAergic local circuit neurones of rat thalamus by a transient K+ current. J Physiol (1994) 1.23
A new fixed-array multi-microelectrode system designed for long-term monitoring of extracellular single unit neuronal activity in vitro. Neurosci Lett (1977) 1.22
Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol (1989) 1.22
The microglia/macrophage response in the neonatal rat facial nucleus following axotomy. Brain Res (1998) 1.22
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology (2003) 1.22
Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes. Neuroscience (2007) 1.22
Experimental approach to test the role of actin in axonal transport. Brain Res (1980) 1.21
Binding and internalization of a iodinated substance P analog by cultured anterior pituitary cells. Mol Cell Endocrinol (1989) 1.21
Therapeutic antibodies elicited by immunization against TNF-alpha. Nat Biotechnol (1999) 1.21
Impaired neuroglial activation in interleukin-6 deficient mice. Glia (1997) 1.21
Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res Hum Retroviruses (1994) 1.20
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer (2006) 1.20
Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab (2001) 1.16
Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol Appl Neurobiol (1995) 1.13
Transient host range selection for genetic engineering of modified vaccinia virus Ankara. Biotechniques (2000) 1.13
5'-Nucleotidase of microglial cells in the facial nucleus during axonal reaction. J Neurocytol (1978) 1.13
Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol (2001) 1.12
Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry. Biochem Biophys Res Commun (1992) 1.11
Vaccination with Rev and Tat against AIDS. Vaccine (1999) 1.11
Nitric oxide controls oscillatory activity in thalamocortical neurons. Neuron (1992) 1.10
Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature (1993) 1.09
Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab (1992) 1.09
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Integrin family of cell adhesion molecules in the injured brain: regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. J Comp Neurol (1999) 1.08
Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int J Dev Neurosci (1995) 1.08
Endogenous retroviral elements in human DNA. Cancer Res (1990) 1.07
Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Lett (1995) 1.07
Gene expression during osteogenic differentiation in mandibular condyles in vitro. J Cell Biol (1990) 1.06
Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285). J Cereb Blood Flow Metab (1987) 1.06
Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes. J Virol (1999) 1.06
Microglial reaction in the rat cerebral cortex induced by cortical spreading depression. Brain Pathol (1993) 1.05
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity. J Gen Virol (2001) 1.04
Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS (1992) 1.03
A mammary-specific promoter directs expression of growth hormone not only to the mammary gland, but also to Bergman glia cells in transgenic mice. Mol Endocrinol (1991) 1.03
Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis. Neurogenetics (1997) 1.02
Cytochemical localization of 5'-nucleotidase in glial plasma membranes. Brain Res (1978) 1.02
Expression of growth factor receptors in injured nervous tissue. I. Axotomy leads to a shift in the cellular distribution of specific beta-nerve growth factor binding in the injured and regenerating PNS. J Neurocytol (1987) 1.02
TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer (2006) 1.01
In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut (2005) 1.01
Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia (1996) 1.01
Interleukin-6 and transforming growth factor-beta 1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur J Neurosci (1993) 1.01
Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol (1995) 1.01
Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure. Pflugers Arch (1980) 1.01